Libo Geng
Biographic Data
| ID | 7304174 |
|---|---|
| NAME | Libo Geng |
| GIVEN NAMES | Libo |
| FAMILY NAME | Geng |
| SIGNATURE | GENG L |
| AFFILIATIONS | Guizhou Magic Pharmaceutical (China) |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
The anti-hepatocellular carcinoma effect of Aidi injection was related to the synergistic action of cantharidin, formononetin, and isofraxidin through Birc5, FEN1, and EGFR
ETHNOPHARMACOLOGICAL RELEVANCE: Aidi injection (ADI) is a popular anti-tumor Chinese patent medicine, widely used in clinics for the treatment of hepatocellular carcinoma (HCC) with remarkable therapeutic effects through multiple targets and pathways. However, the scientific evidence of the synergistic role of the complex chemical component system and the potential mechanism for treating diseases are ignored and remain to be elucidated. AIM OF TH…
No prominent works on this page.
The anti-hepatocellular carcinoma effect of Aidi injection was related to the synergistic action of cantharidin, formononetin, and isofraxidin through Birc5, FEN1, and EGFR
ETHNOPHARMACOLOGICAL RELEVANCE: Aidi injection (ADI) is a popular anti-tumor Chinese patent medicine, widely used in clinics for the treatment of hepatocellular carcinoma (HCC) with remarkable therapeutic effects through multiple targets and pathways. However, the scientific evidence of the synergistic role of the complex chemical component system and the potential mechanism for treating diseases are ignored and remain to be elucidated. AIM OF TH…
Beetle Biology and Toxicology Studies (1 works) · Biochemistry (1 works) · Biology (1 works) · Cancer (1 works) · Cancer Research (1 works) · Cell (1 works) · Cell cycle (1 works) · Computational biology (1 works) · Genetics (1 works) · Hepatocellular carcinoma (1 works)